ROCK Home  |  Past & Future Meetings
The R.O.C.K. Society
Friday, February 3rd
10:00 am - 12:00 pm
Executive Committee Meeting
12:30 - 4:40 pm
Registration
*Lunch is not provided
12:30 - 4:50 pm
Exhibit Hall Hours
1:00 - 1:15 pm
Welcome
1:15 - 2:30 pm
Session One: Pathophysiology of Stone Formation
Moderators: Michael E. Lipkin, MD; John C. Lieske, MD
1:15 pm
1. Effects of Clinically Derived Urinary Small Molecules in Calcium Oxalate Lithogenesis
Jose Agudelo
Cleveland Clinic Foundation, Beachwood, OH
1:30 pm
2. A New Mouse Model of Enteric Hyperoxaluria
Lama Nazzal
New York University, New York, NY
1:45 pm
3. Endogenous Synthesis of Oxalate in Calcium Oxalate Stone Formers
Sonia Fargue
University of Alabama at Birmingham, Birmingham, AL
2:00 pm
4. Designing New Approaches to Prevent Crystallization of Kidney Stones
Jeffrey Rimer
University of Houston, Houston, TX
2:15 pm
5. Diverse Oxalate-Degrading Bacteria are Important for Oxalate Homeostasis in Humans
Mangesh Suryavanshi
Lerner Research Institute, Cleveland Clinic, Cleveland, OH
2:30 - 3:15 pm
Session Two: Patient Centered Health Care Delivery
Moderators: Charles D. Scales, MD; Gregory E. Tasian
2:30 pm
6. Specialty Care Following Urinary Stone Disease Diagnosis: Passed Opportunities
John Leppert
Stanford University School of Medicine, Palo Alto, CA
2:45 pm
7. 24-Hour Urine Utilization for Medical Management of Urolithiasis is Increasing According to Medicare
Ali Antar
University of Wisconsin Department of Urology, Madison, WI
3:00 pm
8. Determinants of Quality of Life in Patients with Ureteral Stents; Analysis of Patient Personality and Sociodemographic Factors
Ephrem Olweny
Rush University Medical Center, Chicago, IL
3:15 pm
9. Thematic Development for a Patient-Centered Research Agenda for Kidney Stone Disease
Jonathan Ellison
Medical College of Wisconsin, Milwaukee, WI
3:30 pm
10. Visualizing Episode-Specific Costs For Renal Colic: A Model For Bundle Payment Reform
David Friedlander
University of North Carolina at Chapel Hill, Chapel Hill, NC
3:30 - 4:00 pm
Coffee Break, Visit Exhibitors and Posters
4:00 - 4:40 pm
Session Three: Moderated Poster Session (5 minute presentation)
Moderators: Brian Eisner, MD; Justin B. Ziemba, MD
MP1.
Pressure Bag versus Fluid Management System: Assessing Differences in Infectious Complications
Jackson Cabo
Vanderbilt University Medical Center, Nashville, TN
MP2.
Effects of Thulium Laser Lithotripsy by Stone Composition
Jeffrey Johnson
New York Presbyterian Weill Cornell, New York, NY
MP3.
Rehabilitation of the Catheterized Urinary Bladder
Donald Griffith
Baylor College of Medicine/ Uro-Research, LLC, Houston, TX
MP6.
Oxalate Handling by the Gastrointestinal Tract
Jonathan Whittamore
UT Southwestern Medical Center, Dallas, TX
MP7.
MP8.
4:40 - 5:40 pm
Networking Reception in the Exhibit Hall
Saturday, February 4th
7:30 am - 3:50 pm
Exhibit Hall Hours
7:30 am - 4:40 pm
Registration
7:30 - 8:00 am
Continental Breakfast
8:00 - 9:00 am
Session Four: Ureteroscopy
Moderators: Patrick S. Lowry, MD; Kelly Healy, MD
8:00 am
11. Predictive Models for Severe Symptoms after Ureteroscopy with Stent from the USDRN STENTS Study
Gregory Tasian
Children's Hospital of Philadelphia, Philadelphia, PA
8:15 am
12. Ureteroscopy with CVAC Aspiration System for the Surgical Management of Large Renal Stones
Karen Stern
Mayo Clinic Arizona, Phoenix, AZ
8:30 am
13. Using a Computer Vision-Mediated Analysis to Distinguish Surgeon Experience During Endoscopic Stone
Nicholas Kavoussi
Vanderbilt University Medical Center, Nashville, TN
8:45 am
14. The Quality of Life Impact of Ureteroscopy for Nephrolithiasis
Justin Ziemba
University of Pennsylvania, Philadelphia, PA
9:00 - 10:15 am
Session Five: Diet and Metabolic Stone Disease
Moderators: Thomas Chi, MD; Anna Zisman, MD
9:00 am
15. Consumption of Whole Grains and of Fruits and Vegetables Combined, but Not Fruits or Vegetables Alone
Melanie Betz
University of Chicago, Chicago, IL
9:15 am
16. Plant-Based Meat Alternatives: A Potential Dietary Option for Prevention of Uric Acid Stone Disease
Alan Pao
Stanford University School of Medicine, Palo Alto, CA
9:30 am
17. Associations Between Net Gastrointestinal Alkali Absorption, 24-Hour Urine Lithogenic Factors, and Kidney Stones
Gary Curhan
Brigham and Women's Hospital, Boston, MA
9:45 am
18. Glucose Induced Hypercalciuria Revisited
Megan Prochaska
University of Chicago, Chicago, IL
10:00 am
19. Alkaline Urine During Pregnancy is Associated with Increased Gastrointestinal Alkali Absorption
Vernon Pais
Dartmouth Hitchcock Medical Center, Lebanon, NH
10:15 - 10:45 am
Coffee Break, Visit Exhibitors and Posters
10:45 - 12:00 pm
Session Six: Epidemiologic Insights into Stone Disease
Moderators: Michael Kurtz, MD, MPH; Nicole L. Miller, MD
10:45 am
20. Differences in Papillary Morphology between Black and White Stone Formers
Luke Reynolds
University of Chicago, Chicago, IL
11:00 am
21. Prevalence of Kidney Stone Disease Among American Indian Adults in the Strong Heart Family Study
Joseph Crivelli
University of Alabama at Birmingham, Birmingham, AL
11:15 am
22. Kidney Stone Events after Kidney Transplant in the United States
Calyani Ganesan
Stanford University School of Medicine, Palo Alto, CA
11:30 am
23. Rock or No Rock: Determinants of Calcium-Containing Kidney Stone Recurrence Over a 10-Year Period.
Rupam Ruchi
University of Florida, Gainesville, FL
11:45 am
24. Association of Dietary Vitamin E Intake on Current Stone Formation: A NHANES Analysis 2017-2020
Vikram Lyall
Dartmouth Hitchcock Medical Center, Labanon, NH
12:00 - 1:00 pm
Industry Sponsored Lunch
1:00 - 2:00 pm
Business Meeting
*Business Meeting for members only
2:00 - 3:00 pm
Session Seven: Basic Science / Molecular and Genetic Determinants of Stone Disease
Moderators: Jeffrey A. Wesson, MD, PhD; Tanecia Mitchell, PhD
2:00 pm
25. OXGR1 is a Candidate Disease Gene for Human Calcium Oxalate Nephrolithiasis
Amar Majmundar
Boston Children's Hospital, Boston, MA
2:15 pm
26. Antibiotic Resistance Gene Presence Leads to Increased Infection in Individuals with Ureteral Stents
Sromona Mukherjee
Cleveland Clinic Foundation, Cleveland, OH
2:30 pm
27. Claudin-2 in Monocyte Activation on Papillary Calcification and Stone Disease
Muthuvel Jayachandran
Mayo Clinic College of Medicine and Science, Rochester, MN
2:45 pm
28. The Use of Genetic Testing for the Management of Nephrolithiasis: Knowns and Unknowns
Karen Stern
Mayo Clinic Arizona, Phoenix, AZ
3:00 - 3:30 pm
Coffee Break, Visit Exhibitors and Posters
3:30 - 4:45 pm
Session Eight: Implications of Access to Care
Moderators: Kevan Sternberg, MD; Karen Stern, MD
3:30 pm
29. Access to Care and Healthcare Utilization Among a Diverse Group of Patients with Nephrolithiasis
Kevin Wymer
Mayo Clinic, Phoenix, AZ
3:45 pm
30. Vulnerability to Financial Toxicity after Renal Stone Surgery
Justin Ziemba
University of Pennsylvania, Philadelphia, PA
4:00 pm
31. Time to Stone Surgery and its Effect on Surgical Treatment Complexity
David Bayne
University of California, San Francisco, San Francisco, CA
4:15 pm
32. Disparities in Care and Outcomes in Adults Hospitalized for Septic Stones
Charles Scales
Duke University, Durham, NC
4:30 pm
33. Does Kidney Stone Treatment Before Pregnancy Impact Subsequent Obstetric Outcomes?: Analysis of a Contemporary Nationwide Cohort
Ephrem Olweny
Rush University Medical Center, Chicago, IL
6:00 pm
Reception offsite in the Parris Hall at Ned Devine's
1 Faneuil Hall Marketplace
Boston, MA